SCHEMBL31269268

SCHEMBL31269268

Cc1cnc(Cn2c(-c3ccc(OC[C@H]4CCCN4C)cc3Cl)nc3c(OC4(C)CC4)ncnc32)s1

nearest known ligand 0.43

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CHRNB4 P30926 11/20 0.40
▸ CHRNA3 P32297 11/20 0.40
▸ CHRNB1 P11230 10/20 0.40
▸ CHRNB2 P17787 10/20 0.40
▸ CHRNB3 Q05901 10/20 0.40
▸ CHRNA4 P43681 2/20 0.39
▸ CHRNA7 P36544 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269171 0.86 DRD2 (0.37) —
SCHEMBL31269436 0.86 CHRNA3 (0.36) CHRNA3CHRNB2CHRNA4
SCHEMBL31269323 0.86 HRH4 (0.40) —
SCHEMBL31269245 0.85 PIK3CD (0.35) —
SCHEMBL31268969 0.85 PIK3CD (0.37) —
SCHEMBL31269192 0.84 PIK3CD (0.37) —
SCHEMBL31268820 0.83 PIK3CD (0.33) —
SCHEMBL31269018 0.83 PIK3CD (0.33) —
SCHEMBL31269378 0.83 PIK3CD (0.34) —
SCHEMBL31268797 0.83 TLR7 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback